After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for […]

Nearly four years removed from a disastrous sales fraud probe and an overhaul of its senior leadership, Alexion […]

With eight COVID-19 vaccines in human testing and headlines touting their progress each day, a leading U.S. health official voiced some […]

Peptides represent a billion-dollar market in the pharmaceutical industry, but they can generally only be taken as injections […]

The coronavirus pandemic has exposed the vulnerability and weaknesses of already fragile global food systems, say the authors […]

A GP who was suspended for forging his supervisor’s signature when he was a trainee may resume work […]

The UK government must alter its current strategy for tackling covid-19 or face a further wave of infections […]

Around half of England’s population is now served by an ICS

The Phase III IKEMA trial hit its primary endpoint

The research funded will help inform policy decisions during the novel coronavirus pandemic